CA
NZ
UK
AU
IND
US
…
BATM Advanced Communications Ltd., together with its subsidiaries, engages in the development, production, and supply of real-time technologies and associated services in Israel, the United States, and Europe. It operates through four segments: Cyber, Networking, Diagnostics, and Non-core. The Cyber segment provides integrated hardware and software solutions for network encryption, including hardware security modules. The Networking segment engages in researching and developing, and marketing of data communication products, including Edgility, an open edge software platform that enables the deployment and life-cycle management of apps, network functions, and compute devices at the edge of the network; and a range of carrier grade products for switching and routing hardware and software products. The Diagnostics segment is involved in the development, sale, and distribution of in vitro diagnostics reagents and instruments, including proprietary products that focus on molecular diagnostics by test type and infectious disease by application area. The Non-core segment distributes pharmaceutical and environmental monitoring products, as well as engages in the production of ecofriendly pathogenic waste treatment solutions for medical, agricultural, and pharmaceutical applications. The company provides software services, such as training and technical support; laboratory service and maintenance; and construction contract services. BATM Advanced Communications Ltd. was incorporated in 1992 and is headquartered in Hod Hasharon, Israel.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Income before tax | -5.73M | 1.95M | 1.90M | 24.93M | 13.30M |
| Minority interest | -0.04M | 0.01M | -0.63M | -0.42M | -3.83M |
| Net income | -22.30M | -0.19M | 1.56M | 14.34M | 9.79M |
| Selling general administrative | 3.81M | 15.13M | 13.02M | 12.24M | 15.88M |
| Selling and marketing expenses | 3.78M | 19.13M | 17.21M | 18.29M | 20.20M |
| Gross profit | 36.80M | 38.30M | 37.96M | 51.06M | 60.71M |
| Reconciled depreciation | 4.97M | 5.18M | 4.89M | 5.26M | 5.47M |
| Ebit | -4.00M | 2.83M | 3.13M | 24.38M | 14.23M |
| Ebitda | 0.97M | 8.01M | 8.80M | 31.11M | 20.53M |
| Depreciation and amortization | 4.97M | 5.18M | 5.66M | 6.73M | 6.29M |
| Operating income | -4.66M | 2.73M | 3.13M | 24.38M | 14.23M |
| Other operating expenses | 122.00M | 114.00M | 112.99M | 115.66M | 169.33M |
| Interest expense | 1.39M | 1.29M | 2.01M | 0.91M | 1.75M |
| Tax provision | 1.73M | 0.84M | 0.34M | 9.34M | 1.04M |
| Interest income | 0.42M | 1.03M | 0.73M | 1.47M | 0.82M |
| Net interest income | -0.97M | -0.35M | -0.60M | 0.56M | -0.93M |
| Income tax expense | 1.73M | 0.78M | 0.34M | 9.34M | 1.04M |
| Total revenue | 117.34M | 116.73M | 116.12M | 140.04M | 183.57M |
| Total operating expenses | 41.46M | 35.57M | 34.82M | 26.68M | 46.48M |
| Cost of revenue | 80.54M | 82.94M | 78.17M | 88.98M | 122.86M |
| Total other income expense net | -1.07M | -0.78M | -1.24M | 0.56M | -0.93M |
| Net income from continuing ops | -7.46M | -0.20M | 0.87M | 14.76M | 11.48M |
| Net income applicable to common shares | - | - | 0.24M | 14.34M | 9.79M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 149.16M | 174.63M | 175.18M | 193.16M | 200.11M |
| Intangible assets | 8.00M | 8.02M | 5.95M | 4.65M | 6.88M |
| Other current assets | 8.10M | 6.88M | - | 34.93M | 41.47M |
| Total liab | 56.18M | 55.19M | 61.18M | 69.03M | 81.34M |
| Total stockholder equity | 94.06M | 120.34M | 115.07M | 127.42M | 122.59M |
| Other current liab | 16.64M | 16.55M | 0.82M | 6.55M | 3.05M |
| Common stock | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M |
| Capital stock | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M |
| Retained earnings | -302.16M | -279.77M | -279.58M | -279.89M | -290.09M |
| Other liab | - | - | 4.13M | 4.68M | 7.96M |
| Good will | 3.34M | 12.76M | 12.58M | 11.38M | 16.84M |
| Other assets | - | - | 3.98M | 5.11M | 7.64M |
| Cash | 25.90M | 32.34M | 35.16M | 65.33M | 50.58M |
| Total current liabilities | 46.58M | 47.13M | 51.29M | 57.89M | 64.27M |
| Net debt | -17.25M | -23.25M | -25.18M | -55.05M | -33.85M |
| Short term debt | 6.29M | 5.11M | 4.22M | 3.82M | 7.61M |
| Short long term debt | 4.26M | 3.28M | 2.23M | 1.63M | 5.37M |
| Short long term debt total | 8.65M | 9.08M | 9.98M | 10.28M | 16.72M |
| Other stockholder equity | 429.60M | 398.79M | 393.33M | 405.99M | 411.36M |
| Property plant equipment | - | - | 20.77M | 24.68M | 25.72M |
| Total current assets | 98.55M | 110.21M | 115.12M | 133.65M | 128.74M |
| Net tangible assets | - | - | 96.54M | 111.39M | 98.88M |
| Short term investments | 5.67M | 8.43M | 9.01M | 2.43M | 2.80M |
| Net receivables | 26.18M | 24.33M | 25.61M | 34.93M | 35.00M |
| Long term debt | 0.00M | 1.33M | 2.00M | 1.36M | 0.68M |
| Inventory | 32.71M | 38.23M | 34.46M | 30.95M | 33.89M |
| Accounts payable | 20.90M | 22.53M | 46.26M | 47.52M | 53.62M |
| Accumulated other comprehensive income | -34.69M | -29.86M | - | - | - |
| Common stock total equity | - | - | - | - | 1.32M |
| Non currrent assets other | 6.22M | 12.54M | 9.63M | 4.17M | 4.68M |
| Non current assets total | 50.61M | 64.42M | 60.06M | 59.52M | 71.37M |
| Capital lease obligations | 4.39M | 4.48M | 5.74M | 7.29M | 10.68M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Investments | -1.22M | -6.12M | -16.34M | -0.33M | -1.91M |
| Change to liabilities | - | - | 0.00M | -5.35M | 7.11M |
| Total cashflows from investing activities | -1.22M | -6.12M | -16.34M | 15.07M | -5.48M |
| Net borrowings | -0.10M | 0.00M | -0.74M | -5.00M | -3.30M |
| Total cash from financing activities | -2.61M | -2.16M | -7.05M | -4.94M | -3.25M |
| Change to operating activities | - | - | - | -3.43M | 2.21M |
| Net income | -4.66M | -0.19M | 3.13M | 24.38M | 14.23M |
| Change in cash | -6.44M | -2.82M | -30.18M | 14.76M | 9.99M |
| Begin period cash flow | 32.34M | 35.16M | 65.33M | 50.58M | 40.58M |
| End period cash flow | 25.90M | 32.34M | 35.16M | 65.33M | 50.58M |
| Total cash from operating activities | -1.65M | 5.01M | -2.78M | 5.59M | 18.46M |
| Issuance of capital stock | - | - | 0.00M | 0.06M | 0.05M |
| Depreciation | 4.97M | 5.18M | 4.89M | 5.26M | 5.47M |
| Other cashflows from investing activities | -1.92M | -1.84M | - | 0.00M | 0.10M |
| Dividends paid | - | - | 4.30M | 4.30M | 4.30M |
| Change to inventory | -0.52M | -4.00M | -3.26M | 3.03M | -11.20M |
| Change to account receivables | -1.20M | 4.61M | - | -2.05M | 0.92M |
| Sale purchase of stock | - | 0.00M | -1.32M | - | 0.05M |
| Other cashflows from financing activities | -2.51M | -2.16M | 9.59M | 8.26M | 10.55M |
| Change to netincome | - | - | -1.01M | -6.21M | 4.15M |
| Capital expenditures | 3.41M | 2.37M | 4.47M | 3.29M | 3.71M |
| Change in working capital | -4.33M | -3.58M | -6.91M | -4.37M | -0.96M |
| Stock based compensation | 0.94M | 2.52M | 0.30M | 0.10M | 0.16M |
| Other non cash items | 1.43M | 1.09M | -4.20M | -19.77M | -0.45M |
| Free cash flow | -5.06M | 2.64M | -7.25M | 2.30M | 14.74M |
Sector: Healthcare Industry: Medical Instruments & Supplies
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BVC Batm Advanced Communications Ltd |
-0.25 2.16% |
11.30 | - | 39.53 | 0.36 | 0.90 | 0.37 | 2.44 |
| CTEC ConvaTec Group PLC |
-4.20 1.71% |
240.80 | 37.27 | 14.66 | 1.79 | 3.77 | 2.94 | 13.89 |
| AMS Advanced Medical Solutions Group plc |
1.00 0.35% |
283.00 | 40.60 | 16.84 | 1.92 | 1.66 | 2.16 | 11.16 |
| TSTL Tristel |
- -% |
407.50 | 23.75 | 19.08 | 3.68 | 5.29 | 3.43 | 13.18 |
| SPEC Inspecs Group plc |
-3.00 3.33% |
87.00 | - | 16.16 | 0.43 | 0.95 | 0.62 | 7.94 |
BATM Advanced Communications Ltd., together with its subsidiaries, engages in the development, production, and supply of real-time technologies and associated services in Israel, the United States, and Europe. It operates through four segments: Cyber, Networking, Diagnostics, and Non-core. The Cyber segment provides integrated hardware and software solutions for network encryption, including hardware security modules. The Networking segment engages in researching and developing, and marketing of data communication products, including Edgility, an open edge software platform that enables the deployment and life-cycle management of apps, network functions, and compute devices at the edge of the network; and a range of carrier grade products for switching and routing hardware and software products. The Diagnostics segment is involved in the development, sale, and distribution of in vitro diagnostics reagents and instruments, including proprietary products that focus on molecular diagnostics by test type and infectious disease by application area. The Non-core segment distributes pharmaceutical and environmental monitoring products, as well as engages in the production of ecofriendly pathogenic waste treatment solutions for medical, agricultural, and pharmaceutical applications. The company provides software services, such as training and technical support; laboratory service and maintenance; and construction contract services. BATM Advanced Communications Ltd. was incorporated in 1992 and is headquartered in Hod Hasharon, Israel.
| Name | Title | Year Born |
|---|---|---|
| Dr. Zvi Marom | Founder, CEO & Exec. Director | 1955 |
| Mr. Moti Nagar | CFO & Exec. Director | NA |
| Mr. Ariel Efrati | COO of Telecom Division & CEO of Telco Systems | NA |
| Mr. Yair Livneh | Company Sec. | NA |
| Mr. Moti Nagar CPA | CEO & Executive Director | NA |
| Mr. Leor Miles CPA | CFO & Executive Director | NA |
| Mr. Haim Schwartz | Chief Operating Officer | NA |
| Mr. Yair Livneh | Company Secretary | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.61%
Communication Services
-0.21%
Consumer Cyclical
-0.26%
Consumer Defensive
-0.37%
Energy
+0.23%
Financial Services
-0.43%
Financials
+0.39%
Healthcare
+0.88%
Industrials
+0.36%
Real Estate
-0.51%
Technology
+1.35%
Utilities
+0.19%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...